25 Stocks Moving in Monday's Pre-Market Session

Gainers

Society Pass Incorporated (NASDAQ:SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
Verso Corporation (NYSE:VRS) rose 32% to $26.45 in pre-market trading after the company agreed to be acquired by BillerudKorsnäs AB for $27 per share in cash.
SeaChange International, Inc. (NYSE:SEAC) rose 16.9% to $1.80 in pre-market trading after declining around 8% on Friday. SeaChange recently reported better-than-expected Q3 results.
GBS Inc. (NASDAQ:GBS) rose 16.7% to $1.47 in pre-market trading after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
Ocugen, Inc. (NASDAQ:OCGN) rose 13.7% to $5.96 in pre-market trading. Ocugen recently announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, medRxiv.
Alpha Pro Tech, Ltd. (NYSE:APT) rose 9.8% to $6.60 in pre-market trading. Alpha Pro Tech recently added $2 million to its buyback program.
Calliditas Therapeutics AB (NASDAQ:CALT) rose 9.4% to $25.67 in pre-market trading. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
Novavax, Inc. (NASDAQ:NVAX) rose 7.7% to $233.97 in pre-market trading. Novavax and Serum Institute of India said the World Health Organization has granted Emergency Use Listing for NVX-CoV2373 COVID-19 vaccine.
Zosano Pharma Corporation (NASDAQ:ZSAN) rose 7.6% to $0.5485 in pre-market trading after dropping around 5% on Friday. Zosano Pharma recently announced changes to board of directors.
Allied Healthcare Products, Inc. (NASDAQ:AHPI) rose 6.4% to $6.17 in pre-market trading after gaining around 4% on Friday.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares rose 6.4% to $0.50 in pre-market trading. Sonnet BioTherapeutics, on Friday, disclosed its financial results for the fiscal year ended September 30th, 2021 and provided a business update.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Society Pass Incorporated (NASDAQ:SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
Verso Corporation (NYSE:VRS) rose 32% to $26.45 in pre-market trading after the company agreed to be acquired by BillerudKorsnäs AB for $27 per share in cash.
SeaChange International, Inc. (NYSE:SEAC) rose 16.9% to $1.80 in pre-market trading after declining around 8% on Friday. SeaChange recently reported better-than-expected Q3 results.
GBS Inc. (NASDAQ:GBS) rose 16.7% to $1.47 in pre-market trading after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
Ocugen, Inc. (NASDAQ:OCGN) rose 13.7% to $5.96 in pre-market trading. Ocugen recently announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, medRxiv.
Alpha Pro Tech, Ltd. (NYSE:APT) rose 9.8% to $6.60 in pre-market trading. Alpha Pro Tech recently added $2 million to its buyback program.
Calliditas Therapeutics AB (NASDAQ:CALT) rose 9.4% to $25.67 in pre-market trading. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
Novavax, Inc. (NASDAQ:NVAX) rose 7.7% to $233.97 in pre-market trading. Novavax and Serum Institute of India said the World Health Organization has granted Emergency Use Listing for NVX-CoV2373 COVID-19 vaccine.
Zosano Pharma Corporation (NASDAQ:ZSAN) rose 7.6% to $0.5485 in pre-market trading after dropping around 5% on Friday. Zosano Pharma recently announced changes to board of directors.
Allied Healthcare Products, Inc. (NASDAQ:AHPI) rose 6.4% to $6.17 in pre-market trading after gaining around 4% on Friday.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares rose 6.4% to $0.50 in pre-market trading. Sonnet BioTherapeutics, on Friday, disclosed its financial results for the fiscal year ended September 30th, 2021 and provided a business update.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Spruce Biosciences, Inc. (NASDAQ:SPRB) fell 16.5% to $4.20 in pre-market trading. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) fell 16.3% to $2.67 in pre-market trading. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc)..
Immix Biopharma, Inc. (NASDAQ:IMMX) fell 15% to $3.40 in pre-market trading amid post-IPO volatility.
Iris Energy Limited (NASDAQ:IREN) fell 12.2% to $15.55 in pre-market trading after climbing 26% on Friday.
Avinger, Inc. (NASDAQ:AVGR) shares fell 11.9% to $0.4670 in pre-market trading. Avinger, last month, announced FDA clearance of pantheris for the treatment of in-stent restenosis.
Argo Blockchain plc (NASDAQ:ARBK) fell 9.4% to $11.75 in pre-market trading after rising around 5% on Friday.
Arqit Quantum Inc. (NASDAQ:ARQQ) shares fell 9.3% to $18.06 in pre-market trading after jumping 22% on Friday.
cbdMD, Inc. (NYSE:YCBD) shares fell 9% to $1.21 in pre-market trading. cbdMD reported FY21 net sales of $44.5 million, versus $41.8 million in FY20.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) shares fell 8.8% to $0.6737 in pre-market trading. Eloxx Pharmaceuticals shares climbed 12% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $4 price target.
Arbutus Biopharma Corporation (NASDAQ:ABUS) shares fell 8.2% to $3.93 in pre-market trading following a 10% surge on Friday.
Zhihu Inc. (NYSE:ZH) shares fell 8.2% to $5.25 in pre-market trading.
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) fell 7.7% to $3.11 in pre-market trading after declining around 6% on Friday.
Laredo Petroleum, Inc. (NYSE:LPI) fell 6.9% to $54.90 in pre-market trading.
Catalyst Biosciences, Inc. (NASDAQ:CBIO) fell 6% to $0.9494 in pre-market trading.